Active Ingredient(s):Tirbanibulin FDA Approved: * December 14, 2020 Pharm Company: *ALMIRALL Category:Skin Care
Tirbanibulin, sold under the brand name Klisyri, is a medication for the treatment of actinic keratosis on the face or scalp.
The most common side effects include local skin reactions, application site pruritus, and application site pain.
Tirbanibulin was approved for medical use in the United States in December 2020, and in the European Unio...
* May have multiple approval dates, manufacturers, or labelers.